Similar articles

• Idarubicin plus ARA-C followed by allogeneic or autologous bone marrow transplantation in advanced acute lymphoblastic leukemia.

  Arcese W, Meloni G, Giona F, Vegna ML, Testi AM, Annino L, Iori AP, Carotenuto M, Resegotti L, Madon E, et al. Arcese W, et al. Bone Marrow Transplant. 1991;7 Suppl 2:38. Bone Marrow Transplant. 1991. PMID: 1878711 Clinical Trial. No abstract available.
• [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].

  Badell I, Ortega JJ, Muñoz A, Bureo E, Madero L, Olivé T, Cubells J, Maldonado MS, Baro J, Díaz MA. Badell I, et al. Sangre (Barc). 1996 Apr;41(2):101-8. Sangre (Barc). 1996. PMID: 9045349 Spanish.
• Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remission.

  Vey N, Blaise D, Stoppa AM, Bouabdallah R, Lafage M, Sainty D, Cowen D, Viens P, Lepeu G, Blanc AP, et al. Vey N, et al. Bone Marrow Transplant. 1994 Sep;14(3):383-8. Bone Marrow Transplant. 1994. PMID: 7994259
• Autologous bone marrow transplantation in acute lymphoblastic leukemia: biological and clinical aspects.

  Carella AM. Carella AM. Haematologica. 1990 Jan-Feb;75(1):79-83. Haematologica. 1990. PMID: 2186984 Review.
• Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.

  Uderzo C, Dini G, Locatelli F, Miniero R, Tamaro P. Uderzo C, et al. Haematologica. 2000 Nov;85(11 Suppl):47-53. Haematologica. 2000. PMID: 11268324 Review.